ProShare Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-12,797
| Closed | -$872K | – | 1916 |
|
|
2022
Q3 | $872K | Buy |
12,797
+728
| +6% | +$49.6K | ﹤0.01% | 757 |
|
|
2022
Q2 | $386K | Sell |
12,069
-6,255
| -34% | -$200K | ﹤0.01% | 1073 |
|
|
2022
Q1 | $634K | Sell |
18,324
-4,285
| -19% | -$148K | ﹤0.01% | 1139 |
|
|
2021
Q4 | $662K | Buy |
22,609
+1,603
| +8% | +$46.9K | ﹤0.01% | 1273 |
|
|
2021
Q3 | $535K | Sell |
21,006
-5,708
| -21% | -$145K | ﹤0.01% | 1172 |
|
|
2021
Q2 | $936K | Buy |
26,714
+18,114
| +211% | +$635K | ﹤0.01% | 1077 |
|
|
2021
Q1 | $350K | Sell |
8,600
-937
| -10% | -$38.1K | ﹤0.01% | 1697 |
|
|
2020
Q4 | $413K | Sell |
9,537
-352
| -4% | -$15.2K | ﹤0.01% | 1392 |
|
|
2020
Q3 | $545K | Buy |
9,889
+153
| +2% | +$8.43K | ﹤0.01% | 910 |
|
|
2020
Q2 | $615K | Sell |
9,736
-1,946
| -17% | -$123K | ﹤0.01% | 863 |
|
|
2020
Q1 | $597K | Sell |
11,682
-9,195
| -44% | -$470K | ﹤0.01% | 696 |
|
|
2019
Q4 | $1.66M | Sell |
20,877
-1,968
| -9% | -$156K | 0.01% | 659 |
|
|
2019
Q3 | $1.11M | Buy |
22,845
+711
| +3% | +$34.5K | 0.01% | 717 |
|
|
2019
Q2 | $1.16M | Sell |
22,134
-2,821
| -11% | -$148K | 0.01% | 710 |
|
|
2019
Q1 | $1.32M | Buy |
24,955
+1,987
| +9% | +$105K | 0.01% | 694 |
|
|
2018
Q4 | $943K | Sell |
22,968
-4,374
| -16% | -$180K | 0.01% | 724 |
|
|
2018
Q3 | $1.04M | Sell |
27,342
-1,018
| -4% | -$38.7K | 0.01% | 807 |
|
|
2018
Q2 | $1.28M | Buy |
28,360
+1,620
| +6% | +$73.2K | 0.01% | 746 |
|
|
2018
Q1 | $1.29M | Sell |
26,740
-2,283
| -8% | -$110K | 0.01% | 740 |
|
|
2017
Q4 | $1.14M | Buy |
29,023
+1,836
| +7% | +$72.2K | 0.01% | 776 |
|
|
2017
Q3 | $844K | Buy |
27,187
+1,538
| +6% | +$47.7K | 0.01% | 774 |
|
|
2017
Q2 | $702K | Buy |
25,649
+3,827
| +18% | +$105K | 0.01% | 838 |
|
|
2017
Q1 | $804K | Sell |
21,822
-5,490
| -20% | -$202K | 0.01% | 827 |
|
|
2016
Q4 | $395K | Buy |
+27,312
| New | +$395K | ﹤0.01% | 1209 |
|